MacroCure

The NASDAQ Biotech Index is down by nearly 27% since the last peak, the IPO window is virtually shut, there is diminished appetite for secondary offerings, the situation has been made worse by the col

Synthetic biology specialist Intrexon Corp. has shifted its focus exclusively to health care and is selling its agricultural, industrial and other biotechnology businesses. Going forward, Intrexon’s

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy transactions that occurred between Aug. 25 and Sept 2.

Company Changes BAIN , Linda To: Codiak BioSciences Inc. , CFO (January) From: Avalanche Biotechnologies Inc., CFO Phone: 617-716-9107 BAKEWELL , John K. To: Exact Sciences Corp. , CFO (Ja